Recombinant
RabMAb

Recombinant Anti-B MyB (phospho T487) antibody [EPR2204Y] (ab76009)

Publishing research using ab76009? Please let us know so that we can cite the reference in this datasheet.

ab76009 has been referenced in 6 publications.

  • Werwein E  et al. Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization. Nucleic Acids Res 47:103-121 (2019). PubMed: 30321399
  • Qiao A  et al. The transcriptional regulator of the chaperone response HSF1 controls hepatic bioenergetics and protein homeostasis. J Cell Biol 216:723-741 (2017). PubMed: 28183717
  • Hauge S  et al. Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading. Oncotarget 8:10966-10979 (2017). PubMed: 28030798
  • Klein DK  et al. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control. Nat Commun 6:5800 (2015). PubMed: 25557911
  • Werwein E  et al. B-Myb switches from Cyclin/Cdk-dependent to Jnk- and p38 kinase-dependent phosphorylation and associates with SC35 bodies after UV stress. Cell Death Dis 4:e511 (2013). ICC/IF ; Mouse, Human . PubMed: 23449447
  • Sadasivam S  et al. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 26:474-89 (2012). WB, ChIP, IP ; Human . PubMed: 22391450

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up